Oktem, A. Et Al. 2017. Long-term results of rituximab-intravenous immunoglobulin combination therapy in patients with epidermolysis bullosa acquisita resistant to conventional therapy. JOURNAL OF DERMATOLOGICAL TREATMENT , vol.28, no.1 , 50-54.

Oktem, A., AKAY, B. N., BOYVAT, A., KUNDAKCI, N., Erdem, C., BOSTANCI, S., ... ŞANLI, H.(2017). Long-term results of rituximab-intravenous immunoglobulin combination therapy in patients with epidermolysis bullosa acquisita resistant to conventional therapy. JOURNAL OF DERMATOLOGICAL TREATMENT , vol.28, no.1, 50-54.

Oktem, AYŞE Et Al. "Long-term results of rituximab-intravenous immunoglobulin combination therapy in patients with epidermolysis bullosa acquisita resistant to conventional therapy," JOURNAL OF DERMATOLOGICAL TREATMENT , vol.28, no.1, 50-54, 2017

Oktem, AYŞE Et Al. "Long-term results of rituximab-intravenous immunoglobulin combination therapy in patients with epidermolysis bullosa acquisita resistant to conventional therapy." JOURNAL OF DERMATOLOGICAL TREATMENT , vol.28, no.1, pp.50-54, 2017

Oktem, A. Et Al. (2017) . "Long-term results of rituximab-intravenous immunoglobulin combination therapy in patients with epidermolysis bullosa acquisita resistant to conventional therapy." JOURNAL OF DERMATOLOGICAL TREATMENT , vol.28, no.1, pp.50-54.

@article{article, author={AYŞE ÖKTEM Et Al. }, title={Long-term results of rituximab-intravenous immunoglobulin combination therapy in patients with epidermolysis bullosa acquisita resistant to conventional therapy}, journal={JOURNAL OF DERMATOLOGICAL TREATMENT}, year=2017, pages={50-54} }